Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity
- 14 January 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 45 (1), 119-124
- https://doi.org/10.1002/ijc.2910450121
Abstract
TIL were cultured from human renal-cell carcinoma (RCC) in 1,000 U/ml rIL2 and restimulated with autologous tumor in efforts to establish which conditions would best expand the number of lymphocytes cytotoxic for autologous tumor. Greater cell yields resulted from multiple restimulations of TIL with autologous tumor. In most instances, these TIL lysed autologous tumor better than TIL grown in rIL2 alone. Enhanced proliferation was seen also after restimulation of TIL with allogeneic RCC as well as with tumor cells of non-renal origin. Although in some instances lysis of autologous tumor appeared to be specific, restimulation with autologous tumor did not consistently result in the generation of specific cytolytic T cells. Attempts to culture more specific cytolytic T cells by using 50 U/ml rIL2 were successful in expanding TIL with enhanced lytic activity; however, this activity was not specific for autologous tumor. The phenotype of the tumorrestimulated TIL generally did not change. In most of the TIL cultures, CD3+ CD4+ cells were predominant with low numbers of CD3+ Leu19+ cells and minimal numbers of CD3-Leu 19+ cells. Thus, the cytotoxic response to tumor was mediated by T cells and not NK cells. Overall, our data indicate that restimulation of TIL with autologous tumor may be beneficial for growing larger numbers of cells which have increased lytic activity and for prolonging the presence of lytic activity among the expanded TIL.This publication has 18 references indexed in Scilit:
- TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCERThe Lancet, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988
- Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.The Journal of Experimental Medicine, 1988
- Tumor‐Infiltrating Lymphocytes in Patients with Renal‐Cell CarcinomaAnnals of the New York Academy of Sciences, 1988
- Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.The Journal of Immunology, 1988
- Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2Cancer Immunology, Immunotherapy, 1988
- Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.The Journal of Immunology, 1987
- Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancerCancer Immunology, Immunotherapy, 1987
- Functional characterization of T lymphocytes propagated from human lung carcinomasClinical Immunology and Immunopathology, 1986